- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
Finder makes money from featured partners, but editorial opinions are our own.
Advertiser disclosure
Pharming Group N.V. is a biotechnology business based in the US. Pharming Group N.V. shares (PHAR) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $8.89 – an increase of 1.72% over the previous week. Pharming Group N.V. employs 382 staff and has a trailing 12-month revenue of around $285.7 million.
Our top picks for where to buy Pharming Group stock
- Trade $0 commission stocks & ETFs with as little as $1
- Earn up to $300 with qualifying deposits
- Discover new opportunities with Opto's AI-driven thematic investing system
- Theme and ETF screener
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options with no options contract fees
- Get up to $1,000 in stock when you fund a new account within 30 days
- Complimentary access to a financial planner
Probability of member receiving $1,000 is 0.028%
How to buy Pharming Group N.V. stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – PHAR. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Pharming Group N.V. stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.1 - 5 of 5
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Pharming Group N.V. stock price (NASDAQ: PHAR)
Use our graph to track the performance of PHAR stocks over time.Pharming Group N.V. shares at a glance
Information last updated 2024-12-12.
| Latest market close | $8.89 |
|---|---|
| 52-week range | $6.65 - $13.20 |
| 50-day moving average | $8.24 |
| 200-day moving average | $8.86 |
| Wall St. target price | $27.00 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-0.27 |
Is it a good time to buy Pharming Group N.V. stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Pharming Group N.V. price performance over time
Historical closes compared with the close of $8.9823 from 2024-12-13
| 1 week (2024-12-10) | 2.77% |
|---|---|
| 1 month (2024-11-15) | 9.81% |
| 3 months (2024-09-16) | 15.16% |
| 6 months (2024-06-14) | 4.45% |
| 1 year (2023-12-15) | -23.88% |
|---|---|
| 2 years (2022-12-16) | -19.25% |
| 3 years (2021-12-16) | 8.35% |
| 5 years (2019-12-13) | N/A |
Pharming Group N.V. financials
| Revenue TTM | $285.7 million |
|---|---|
| Operating margin TTM | 5.49% |
| Gross profit TTM | $188.1 million |
| Return on assets TTM | -1.38% |
| Return on equity TTM | -8.18% |
| Profit margin | -6.24% |
| Book value | $0.44 |
| Market Capitalization | $628.8 million |
TTM: trailing 12 months
Pharming Group N.V. share dividends
We're not expecting Pharming Group N.V. to pay a dividend over the next 12 months.
You may also wish to consider:
Pharming Group N.V. share price volatility
Over the last 12 months, Pharming Group N.V.'s shares have ranged in value from as little as $6.65 up to $13.2. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Pharming Group N.V.'s is 0.811. This would suggest that Pharming Group N.V.'s shares are less volatile than average (for this exchange).
To put Pharming Group N.V.'s beta into context you can compare it against those of similar companies.
- Alexion Pharmaceuticals (ALXN.US): 1.2595
- Repligen Corporation (RGEN.US): 0.959
- Teva Pharma Industries Ltd ADR (TEVA.US): 0.868
Pharming Group N.V. overview
Pharming Group N. V. , a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company offers RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K" inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of HAE. The company has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105. Pharming Group N.
Frequently asked questions
What percentage of Pharming Group N.V. is owned by institutions?Currently 0.102% of Pharming Group N.V. shares are held by institutions. How many people work for Pharming Group N.V.?
Latest data suggests 382 work at Pharming Group N.V.. When does the fiscal year end for Pharming Group N.V.?
Pharming Group N.V.'s fiscal year ends in December. Where is Pharming Group N.V. based?
Pharming Group N.V.'s address is: Darwinweg 24, Leiden, Netherlands, 2333 CR What is Pharming Group N.V.'s ISIN number?
Pharming Group N.V.'s international securities identification number is: US71716E1055
More resources on Finder
More guides on Finder
-
Best Stocks for Beginners With Little Money to Invest
These are the stocks to buy when you don’t have much to spend.
-
Sweep Accounts
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
7 Best Day Trading Apps of 2024
These are the best day trading apps, according to Finder’s comprehensive analysis.
-
Today’s Best Brokerage Account Bonuses [Signup and Transfer Promos]
Explore the best bonuses for opening a new brokerage account.
-
5 best stock picking services of 2024
Compare the 5 best stock picking services, according to Finder’s analysis, and learn how to choose the best option for your needs.
-
5 Top Graphene Stocks to Invest in Today
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
-
Ratings methodology for online brokers
Our star ratings for online brokerages are based on how they stack up in nine key categories.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to Invest $10K
Maximize $10,000 with broker bonuses, IRA contribution matches, index funds, stocks, ladder CDs, hiring a financial advisor and more.
-
5 best ETFs for 2024
Check out the best-performing ETFs so far in 2024.
Ask a question